Ghrelin Does Not Directly Stimulate Secretion of Glucagon-like Peptide-1.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 01 2020
Historique:
received: 08 05 2019
accepted: 20 09 2019
pubmed: 15 10 2019
medline: 29 7 2020
entrez: 15 10 2019
Statut: ppublish

Résumé

The gastrointestinal hormone ghrelin stimulates growth hormone secretion and appetite, but recent studies indicate that ghrelin also stimulates the secretion of the appetite-inhibiting and insulinotropic hormone glucagon-like peptide-1 (GLP-1). To investigate the putative effect of ghrelin on GLP-1 secretion in vivo and in vitro. A randomized placebo-controlled crossover study was performed in eight hypopituitary subjects. Ghrelin or saline was infused intravenously (1 pmol/min × kg) after collection of baseline sample (0 min), and blood was subsequently collected at time 30, 60, 90, and 120 minutes. Mouse small intestine was perfused (n = 6) and GLP-1 output from perfused mouse small intestine was investigated in response to vascular ghrelin administration in the presence and absence of a simultaneous luminal glucose stimulus. Ghrelin receptor expression was quantified in human (n = 11) and mouse L-cells (n = 3) by RNA sequencing and RT-qPCR, respectively. Ghrelin did not affect GLP-1 secretion in humans (area under the curve [AUC; 0-120 min]: ghrelin infusion = 1.37 ± 0.05 min × nmol vs. saline infusion = 1.40 ± 0.06 min × nmol [P = 0.63]), but induced peripheral insulin resistance. Likewise, ghrelin did not stimulate GLP-1 secretion from the perfused mouse small intestine model (mean outputs during baseline/ghrelin infusion = 19.3 ± 1.6/25.5 ± 2.0 fmol/min, n = 6, P = 0.16), whereas glucose-dependent insulinotropic polypeptide administration, used as a positive control, doubled GLP-1 secretion (P < 0.001). Intraluminal glucose increased GLP-1 secretion by 4-fold (P < 0.001), which was not potentiated by ghrelin. Finally, gene expression of the ghrelin receptor was undetectable in mouse L-cells and marginal in human L-cells. Ghrelin does not interact directly with the L-cell and does not directly affect GLP-1 secretion.

Identifiants

pubmed: 31608930
pii: 5586875
doi: 10.1210/clinem/dgz046
pmc: PMC6941855
pii:
doi:

Substances chimiques

Ghrelin 0
Placebos 0
Glucagon-Like Peptide 1 89750-14-1

Banques de données

ClinicalTrials.gov
['NCT01209416']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 106263/Z/14/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 106262/Z/14/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12012/3
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00014/3
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MRC_MC_UU_12012/3
Pays : United Kingdom

Informations de copyright

© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

Diabetes. 2012 Jan;61(1):187-96
pubmed: 22124465
Peptides. 2014 May;55:52-7
pubmed: 24486427
Diabetes. 2001 Aug;50(8):1714-9
pubmed: 11473029
Cell Metab. 2008 Dec;8(6):532-9
pubmed: 19041768
Front Endocrinol (Lausanne). 2017 Jun 19;8:135
pubmed: 28674521
Neurogastroenterol Motil. 2013 Apr;25(4):346-e255
pubmed: 23360316
Endocrinology. 1999 Apr;140(4):1687-94
pubmed: 10098504
Diabetologia. 2013 Oct;56(10):2250-4
pubmed: 23893303
Sci Rep. 2017 Feb 15;7:42706
pubmed: 28198428
Endocrinology. 2015 Mar;156(3):847-57
pubmed: 25535831
J Clin Endocrinol Metab. 2016 Jun;101(6):2405-14
pubmed: 27055279
Regul Pept. 2002 Dec 31;110(1):39-45
pubmed: 12468108
J Clin Endocrinol Metab. 2006 Sep;91(9):3296-302
pubmed: 16772353
Endocrinology. 1993 Jul;133(1):233-40
pubmed: 8319572
Am J Clin Nutr. 1998 Sep;68(3):525-30
pubmed: 9734726
Arch Surg. 2004 Jul;139(7):780-4
pubmed: 15249413
Nature. 1999 Dec 9;402(6762):656-60
pubmed: 10604470
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Vis Exp. 2019 Feb 26;(144):
pubmed: 30882791
Gut. 2006 Mar;55(3):327-33
pubmed: 16216827
J Endocrinol. 2016 Jan;228(1):39-48
pubmed: 26483393
Endocrine. 2001 Feb;14(1):9-14
pubmed: 11322507
Expert Rev Endocrinol Metab. 2014 Jan;9(1):61-72
pubmed: 30743739
PLoS One. 2014 Feb 26;9(2):e89977
pubmed: 24587162
Diabetologia. 2018 Feb;61(2):265-272
pubmed: 28501906
Diabetes Care. 2016 Jun;39(6):884-92
pubmed: 27222546
Diabetes. 2019 May;68(5):1062-1072
pubmed: 30733330
Eur J Endocrinol. 2005 Jun;152(6):845-50
pubmed: 15941923
Mol Cell Endocrinol. 2017 Jul 5;449:64-73
pubmed: 27908836
J Clin Endocrinol Metab. 2003 Jun;88(6):2706-13
pubmed: 12788877
Diabetes. 1994 Apr;43(4):535-9
pubmed: 8138058
Best Pract Res Clin Endocrinol Metab. 2004 Dec;18(4):531-54
pubmed: 15533774
N Engl J Med. 2002 May 23;346(21):1623-30
pubmed: 12023994
Diabetologia. 2012 Sep;55(9):2445-55
pubmed: 22638549
Physiol Rev. 2007 Oct;87(4):1409-39
pubmed: 17928588
J Clin Endocrinol Metab. 2011 Feb;96(2):468-77
pubmed: 21084392
Diabetes. 2015 May;64(5):1513-21
pubmed: 25412624
Scand J Gastroenterol. 1996 Jul;31(7):665-70
pubmed: 8819215
J Clin Endocrinol Metab. 1986 Aug;63(2):492-8
pubmed: 3522621
Annu Rev Physiol. 2016;78:277-99
pubmed: 26442437
Mol Metab. 2015 Mar 21;4(6):437-60
pubmed: 26042199
J Endocrinol Invest. 2010 Oct;33(9):633-9
pubmed: 20339311
Aliment Pharmacol Ther. 2009 Jun 1;29(11):1179-87
pubmed: 19298585
Gastroenterology. 2007 May;132(6):2131-57
pubmed: 17498508
Diabetes. 2017 Aug;66(8):2144-2149
pubmed: 28385801
J Endocrinol Invest. 2001 Jun;24(6):RC19-21
pubmed: 11434675
Mol Endocrinol. 2003 Nov;17(11):2201-10
pubmed: 12907757
Horm Metab Res. 2002 Jul;34(7):411-3
pubmed: 12189591
Diabetes. 2015 Feb;64(2):370-82
pubmed: 25157092

Auteurs

Sara Lind Jepsen (SL)

Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Esben Thyssen Vestergaard (ET)

Medical Research Laboratories Aarhus University, Aarhus N, Denmark.
Department of Pediatrics, Randers Regional Hospital, Randers, Denmark.

Pierre Larraufie (P)

Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, UK.

Fiona Mary Gribble (FM)

Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, UK.

Frank Reimann (F)

Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, University of Cambridge, UK.

Jens Otto Lunde Jørgensen (JOL)

Medical Research Laboratories Aarhus University, Aarhus N, Denmark.

Jens Juul Holst (JJ)

Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Rune Ehrenreich Kuhre (RE)

Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH